Surface Ophthalmics

Manufacturing · California, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

5000 Hopyard Rd Ste 402, Pleasanton, Cal...

Phone Number

(858) 405-4448

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Surface Ophthalmics

Surface Ophthalmics, Inc., based in Pleasanton, CA, is a pharmaceutical company focused on development and commercialization of innovative therapeutics for ocular diseases.Explore more
Surface Ophthalmics's Social MediaPopular SearchesSurface OphthalmicsSurface Ophthalmics IncSIC Code 28,283NAICS Code 32,325Show more

Surface Ophthalmics Org Chart

PhoneEmail
CB
United States flag for contact location.

Vice President, Clinical Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Surface Ophthalmics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Surface Ophthalmics

Compare insights from companies similar to Surface Ophthalmics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Surface Ophthalmics

<$5M
1-10
Private
$25M
2017
CB
Charlotte BaenzigerVice President, Clinical Operations
$6.8M
11-50
Private
-
2000
JW
Jian-Xin WuVice President, Branch (China)
$6.7M
11-50
Private
$74.8M
2006
N/A
<$5M
11-50
Private
<$5M
2020
Francisco Torres, Chief Financial Officer at Forte Bio-Pharma
Francisco TorresChief Financial Officer
<$5M
11-50
Private
-
2001
N/A
<$5M
1-10
Private
-
2014
N/A
<$5M
1-10
Private
-
2020
Francesco Salituro, Founder & Proprietor at Salituro Medchem Solutions
Francesco SalituroFounder & Proprietor
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Surface Ophthalmics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Surface Ophthalmics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Surface Ophthalmics.

Surface Ophthalmics financials insights

Gather financial insights about Surface Ophthalmics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2021

Share Placement

$25M

See All Surface Ophthalmics's Financials Insights

Surface Ophthalmics Tech Stack

A closer look at the technologies used by Surface Ophthalmics

Surface Ophthalmics News & Media

  • Surface Ophthalmics Announces New Leadership with Richard Lindstrom, MD, and Renewed Vision for Addressing Critical Unmet Needs of Dry Eye Syndrome Patients

    PLEASANTON, Calif.--(BUSINESS WIRE)--Surface Ophthalmics, a pioneering biopharmaceutical company, dedicated to transforming the management and treatment of dry eye syndrome (DES), today announced the appointment of Richard Lindstrom, MD as Founder & Chairman. A highly acclaimed physician and surgeon in ophthalmology, Dr. Lindstrom is founder and attending surgeon emeritus at Minnesota Eye Consultants, P.A. Dr. Lindstrom will lead in partnership with Surface’s distinguished Board of Director
  • Surface Ophthalmics Raises $25M in Funding

    Surface Ophthalmics, a Pleasanton CA-based pharmaceutical company, raised $25M in funding. Investors included both new and existing investors made up of institutional, healthcare-focused, and other accredited investors, including members of the Surface Board of Directors. The company intends to use the funds to advance its clinical programs in ocular diseases. Led by Kamran Hosseini, MD, […] The post Surface Ophthalmics Raises $25M in Funding appeared first on FinSMEs.
Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Surface Ophthalmics

What is Surface Ophthalmics's official website?
Surface Ophthalmics's official website is www.surfaceophthalmics.com
What is Surface Ophthalmics's Revenue?
Surface Ophthalmics's revenue is <$5 Million
What is Surface Ophthalmics's SIC code?
Surface Ophthalmics's SIC: 28,283
What is Surface Ophthalmics's NAICS code?
Surface Ophthalmics's NAICS: 32,325
How many employees does Surface Ophthalmics have?
Surface Ophthalmics has 1-10 employees
What industry does Surface Ophthalmics belong to?
Surface Ophthalmics is in the industry of: Manufacturing, Pharmaceuticals
What is Surface Ophthalmics competition?
Surface Ophthalmics top competitors include: Presidio Pharmaceuticals, Glenridge Pharmaceuticals, Salituro Medchem Solutions, Forte Bio-Pharma
What technology does Surface Ophthalmics use?
Some of the popular technologies that Surface Ophthalmics uses are: WordPress.org, reCAPTCHA, PHP, Cloudflare Website Optimization
How do I contact Surface Ophthalmics?
Surface Ophthalmics contact info: Phone number: (858) 405-4448 Website: www.surfaceophthalmics.com
What does Surface Ophthalmics do?

Surface Ophthalmics, Inc., based in Pleasanton, CA, is a pharmaceutical company focused on development and commercialization of innovative therapeutics for ocular diseases.... Read More

What are Surface Ophthalmics social media links?
Surface Ophthalmics Linkedin page
Is Surface Ophthalmics a public company?
Surface Ophthalmics is private company therefore does not currently have an official ticker symbol
See more information about Surface Ophthalmics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.